Verumontanum hypertrophy in chronic prostatitis.
- Author:
Qing-Zhong CHEN
1
;
Yong FENG
;
Wei LI
;
Jun-Ze ZHANG
;
Shao-Feng YAN
;
Wen-Zhang CHEN
;
Li JING
;
Tao SHI
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Chronic Disease; Genitalia, Male; pathology; Humans; Hypertrophy; Male; Middle Aged; Prostatitis; etiology; pathology; Young Adult
- From: National Journal of Andrology 2012;18(5):425-427
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the relationship of verumontanum hypertrophy with chronic prostatitis.
METHODSFifty-two patients with chronic prostatitis underwent cystourethroscopy for comparing the size of the verumontanum before and after treatment.
RESULTSBefore treatment, all the patients showed different degrees verumontanum hypertrophy, of whom 50 were treated by conventional drug therapy, and the other 2 with voiding dysfunction by drug therapy combined with transurethral resection. Cystourethroscopy revealed significantly decreased size of the verumontanum in 44 of the patients after treatment (P < 0.05).
CONCLUSIONPatients with chronic prostatitis often have verumontanum hypertrophy, which could be an indicator of the effect of treatment.
